Act For ALS Boosted Drug Access, But Rollout Faced Initial Hurdles, GAO Says

 
• By Manas Mishra
  
GAO found the initial years of the Act for ALS grant and expanded access programs were bumpy at times. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from United States